Back

The impact of left ventricular reverse remodeling on asymptomatic structual heart disease

31 August 2025 (17:10 - 17:20)
Organised by: Logo
Congress Presentation Part of: Mechanisms of heart failure: emerging evidence Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kazuyo Tanaka

Niigata University, Niigata (Japan)

5 More presentations in this session

Presentation thumbnail
Cardiac amyloidosis and heart failure phenotypes: a prognostic study of systolic function markers
Assistant Professor A. Zaroui (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
Proteomic profiling of circulating exosome identifies CAPG as a key molecule associated with clinical outcomes in heart failure
Doctor S. Okochi (Fukushima, JP)
Abstract Slides Video
Presentation thumbnail
Impact of obesity and breathlessness on MACE outcomes within HFpEF: results from the UK Biobank
Doctor M. Mahmod (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Mismatch between lead I from the 12-Lead ECG and smartwatch ECG: can AI models adapt for left ventricular systolic dysfunction prediction?
Mr J. Jang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Identification of biomarkers for right ventricular dysfunction in dilated cardiomyopathy using urinary proteomics and machine learning
Doctor J. Zhang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of heart failure: emerging evidence
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting
thumbnail
Congress Presentation
LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome
thumbnail
Congress Session
Mechanisms of heart failure: emerging evidence

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources